These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3606814)

  • 1. Vasopressin analogue (DDAVP) facilitates recall of narrative prose.
    Beckwith BE; Petros TV; Bergloff PJ; Staebler RJ
    Behav Neurosci; 1987 Jun; 101(3):429-32. PubMed ID: 3606814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers.
    Beckwith BE; Petros TV; Bergloff PJ; Swenson RR; Paulson R
    Peptides; 1995; 16(8):1327-8. PubMed ID: 8745039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment.
    Till RE; Beckwith BE
    Peptides; 1985; 6(3):397-402. PubMed ID: 4070014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of DDAVP, a vasopressin analog, on delayed matching behavior in the pigeon.
    Teal JJ; Evans HL
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1123-7. PubMed ID: 7163345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent effects of DDAVP on memory in healthy young adult males: a preliminary study.
    Beckwith BE; Till RE; Reno CR; Poland RE
    Peptides; 1990; 11(3):473-6. PubMed ID: 2381872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DDAVP on gender-specific verbal and visuospatial tasks in healthy young adults.
    Beckwith BE; Petros TV; Knutson KK
    Peptides; 1990; 11(6):1313-5. PubMed ID: 2087443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin analog (DDAVP) improves memory in human males.
    Beckwith BE; Till RE; Schneider V
    Peptides; 1984; 5(4):819-22. PubMed ID: 6494028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vasopressin on memory following electroconvulsive therapy.
    Lerer B; Zabow T; Egnal N; Belmaker RH
    Biol Psychiatry; 1983 Jul; 18(7):821-4. PubMed ID: 6615939
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of vasopressin on human memory functions.
    Weingartner H; Gold P; Ballenger JC; Smallberg SA; Summers R; Rubinow DR; Post RM; Goodwin FK
    Science; 1981 Feb; 211(4482):601-3. PubMed ID: 7455701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttrial treatment with ethanol enhances recall of prose narratives.
    Lamberty GJ; Beckwith BE; Petros TV; Ross AR
    Physiol Behav; 1990 Nov; 48(5):653-8. PubMed ID: 2082365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and memory: improvement in normal short-term recall and reduction of alcohol-induced amnesia.
    Millar K; Jeffcoate WJ; Walder CP
    Psychol Med; 1987 May; 17(2):335-41. PubMed ID: 3602225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin analog influences the performance of males on a reaction time task.
    Beckwith BE; Couk DI; Till TS
    Peptides; 1983; 4(5):707-9. PubMed ID: 6657514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of smoking on memory for prose passages.
    Krebs SJ; Petros TV; Beckwith BE
    Physiol Behav; 1994 Oct; 56(4):723-7. PubMed ID: 7800739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin peptide (DDAVP) may narrow the focus of attention in normal elderly.
    Jennings JR; Nebes RD; Reynolds CF
    Psychiatry Res; 1986 Jan; 17(1):31-9. PubMed ID: 3945698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.
    Sahgal A; Wright C; Ferrier IN
    Psychopharmacology (Berl); 1986; 90(1):58-63. PubMed ID: 3094063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between a synthetic analogue of vasopressin and human peripheral blood lymphocytes.
    Wickramasinghe SN; Valdimarsson H; Williams B
    J Clin Lab Immunol; 1982 Jan; 7(1):67-70. PubMed ID: 6279851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin (DDAVP) therapy in chronic schizophrenia: effects on negative symptoms and memory.
    Brambilla F; Bondiolotti GP; Maggioni M; Sciascia A; Grillo W; Sanna F; Latina A; Picotti GB
    Neuropsychobiology; 1989; 20(3):113-9. PubMed ID: 2548116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of vasopressin treatment of childhood learning disorder.
    Eisenberg J; Chazan-Gologorsky S; Hattab J; Belmaker RH
    Biol Psychiatry; 1984 Jul; 19(7):1137-41. PubMed ID: 6477993
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of renal concentrating ability with DDAVP and pitressin.
    Herbai G; Ljunghall S
    Scand J Urol Nephrol; 1983; 17(1):69-71. PubMed ID: 6867627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.